Fechar
Active Transport
Address-Message Concept
ADME
Affinity
Agonist
Allosteric Binding Sites.
Allosteric Enzyme
Allosteric Regulation
Analog
Antagonist
Antimetabolite
Antisense Molecule
Autacoid
Autoreceptor
Bacteriocidal
Bacteriostatic
Bioassay
Bioisotere
Bioprecursor Produrg
Biotransformation
Carrier-Linked Prodrug
Cascade Prodrug
Catabolism
Catabolite
Clone
Codon
Coenzyme
Combinatorial Synthesis
Combinatorial Library
Comparative Molecular Field Analysis (CMFA)
Computational Chemistry
Computer-Assisted Drug Design
Congener
Cooperativity
De Novo Design
Distomer
Docking Studies
Double-Blind Study
Double Prodrug/Pro-prodrug
Drug
Drug Disposition
Drug Latentiation
Drug targeting
Dual Action Drug
Efficacy
Elimination
Enzyme
Enzyme Induction
Enzyme Repression
Eudismic Ratio
Eutomer
Genome
Hansch Analysis
Hapten
Hard Drug
Heteroreceptor
Homologue
Hormone
Hydrophilicity
Hydrophobicity
Intrinsic Activity
Inverse Agonist
Isoteres
Lead Discovery
Lead Generation
Lead Optimization
Lipophilicty
Mechanism-based inhibitor
Medicinal Chemistry
Metabolism
Metabolite
Me-too Drug
Molecular Graphics
Molecular Modelling
Mutagen
Mutual Prodrug
New Chemical Entity (NCE)
Nucleic Acid
Nucleoside
Nucleotide
Oligonucleotide
Oncogene
Orphan Drug
Partial Agonist
Pattern recognition
Peptidomimetic
Peptoid
Pfeiffer's Rule
Phramacokinetics
Pharmacophore
Pharmacophoric Descriptors
Placebo
Potency
Prodrug
Quantitative Structure-Activity Relationships (QSAR)
Receptor
Receptor Mapping
Second Messenger
Site-Specific Delivery
Site-specific Delivery
Soft Drug
Strucutre-Activity Relationship (SAR)
Structure-Based Drugs
Structure-Property Correlations (SPC)
Systematic
Teratogen
3D-QSAR
Topliss Tree
Transition-State Analog
Xenobiotic
IC50
Ki
ED50
LD50
Therapeutic Index
Orphan Drug
